Skip to main content

Finance

By Anthony Vecchione | 01:32 pm | December 10, 2024
The company will use the funds to enhance its R&D strategy, advance its SEEDIT platform and boost product development.  
By Jessica Hagen | 02:25 pm | December 09, 2024
Former HealthTap employees allege that Mohr Davidow Ventures and company leaders stripped them of equity to position the company for a profitable turnaround benefiting MDV.
By Jessica Hagen | 04:20 pm | December 04, 2024
The all-cash transaction will see Cross Country transition to a privately held company with its common stock no longer trading on the Nasdaq.
By Anthony Vecchione | 01:16 pm | November 27, 2024
The company will use the funds to try and level the playing field between payers and providers.
By Anthony Vecchione | 01:06 pm | November 27, 2024
The funds will be used to strengthen the company's platform with AI-driven features, increase its product development and meet rising market demand for digital healthcare.
By Anthony Vecchione | 03:05 pm | November 22, 2024
The money will be used to develop new medications and biologicals.  
By Anthony Vecchione | 04:03 pm | November 19, 2024
The company will use the funds to support people who are managing rare and complex conditions.
By Jessica Hagen | 03:35 pm | November 19, 2024
Vitality will integrate WellSpark's coaching tools to enhance the services it offers employers and health plans.
By Anthony Vecchione | 12:33 pm | November 14, 2024
The company will use the funds to strengthen its research and development capabilities.  
By Anthony Vecchione | 02:38 pm | November 13, 2024
The aim of the acquisitions is to accelerate the company's involvement in two major growth areas and improve patient care.